SCHEMBL7804377

SCHEMBL7804377

CC(C)OC(=O)C(C)(C)Oc1cccc(C2CCN(C(=O)c3cccnc3)CC2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
TLR9 Q9NR96 1/20 0.46
TLR8 Q9NR97 1/20 0.46
TLR7 Q9NYK1 1/20 0.46
BCL9 O00512 2/20 0.46
CTNNB1 P35222 2/20 0.46
TDP1 Q9NUW8 1/20 0.45
GAA P10253 1/20 0.45
HTT P42858 1/20 0.43
CYP2C9 P11712 1/20 0.43
SLC9A1 P19634 1/20 0.43
CCR5 P51681 1/20 0.42
PKM P14618 1/20 0.42
MAPK1 P28482 1/20 0.42
EPHX2 P34913 1/20 0.42
LMNA P02545 1/20 0.42
RIPK1 Q13546 1/20 0.41
KMT2A Q03164 1/20 0.41
ABL1 P00519 1/20 0.41
BCR P11274 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7813907 0.91 BCL9 (0.49) TLR9TLR8TLR7BCL9CTNNB1
SCHEMBL7811643 0.89 BCL9 (0.52) ALDH1A1BCL9CTNNB1GAAHTT
SCHEMBL7814105 0.88 BCL9 (0.54) ALDH1A1TLR9TLR8TLR7BCL9
SCHEMBL7804213 0.85 BCL9 (0.49) ALDH1A1BCL9CTNNB1TDP1CYP2C9
SCHEMBL7811471 0.84 PARP10 (0.51) ALDH1A1BCL9CTNNB1LMNAKMT2A
SCHEMBL7817327 0.84 BCL9 (0.48) BCL9CTNNB1TDP1GAAHTT
SCHEMBL7813463 0.84 BCL9 (0.48) BCL9CTNNB1TDP1GAAHTT
SCHEMBL7804520 0.84 HSD11B1 (0.55) ALDH1A1BCL9CTNNB1GAASLC9A1
SCHEMBL7814050 0.84 MEN1 (0.52) BCL9CTNNB1TDP1CYP2C9MAPK1
SCHEMBL7817387 0.84 BCL9 (0.47) BCL9CTNNB1GAAHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed